Imasen China Restructuring Consolidates Production in 2027

Imasen Consolidates Chinese Production Operations

Imasen China Restructuring will consolidate the company's manufacturing operations in China at a single site by the end of March 2027. Imasen Electric Industrial Co Ltd approved a plan to transfer all production at Wuhan Imasen Electric Industrial Co Ltd to Guangzhou Imasen Electric Industrial Co Ltd. After the transfer is completed, Wuhan Imasen will operate solely as a delivery base for customers in the Wuhan area. The restructuring responds to changes in the China automotive market and is intended to align production capacity with demand while improving the utilization of the Guangzhou operation.

Production Transfer Targets Lower Fixed Costs

Imasen has already implemented rationalization measures, including workforce adjustments, in response to changing market conditions in China. Consolidating production is designed to improve capacity utilization at Guangzhou Imasen while reducing fixed costs across the company's Chinese operations. Both Wuhan Imasen and Guangzhou Imasen manufacture and sell automotive components, including seat adjusters and electronic units. Moving production to one site is therefore expected to simplify the manufacturing footprint and better align available capacity with demand. The company is pursuing the consolidation as part of broader efforts to improve the profitability of its overall China business.

Restructuring Costs Expected to Reach JPY 1.2 Billion

Imasen expects to recognize an extraordinary loss of approximately JPY 1.2 billion in its consolidated financial results for the fiscal year ending March 2027. The loss will reflect restructuring-related expenses, including the disposal of fixed assets that will no longer be required after production is consolidated and compensation payments for employees affected by the restructuring. The cost represents the financial impact of implementing the production transfer and associated workforce measures. Despite the expected extraordinary loss, the company has not changed its consolidated earnings forecast for the fiscal year ending March 2027 at this time.

Imasen Plans Securities Sales to Reduce Cross-Shareholdings

Separately, Imasen approved the sale of part of its holdings in two listed securities as part of an effort to reduce cross-shareholdings. The company expects these sales to generate approximately JPY 1.2 billion in gains, which will be recorded as extraordinary income between October 2026 and March 2027. The planned securities disposals therefore provide an offsetting source of extraordinary income during the same fiscal period in which the company expects to incur restructuring costs. Imasen's consolidated earnings forecast remains unchanged, indicating that the company currently expects these restructuring and securities-related items without revising its stated full-year earnings outlook.

Industry Impact & Outlook

The restructuring highlights how automotive component suppliers are adjusting manufacturing footprints in response to changing demand and the need for stronger capacity utilization in China. For Imasen, concentrating production at Guangzhou could create a more efficient operating structure while reducing fixed costs, although the transition will generate significant one-time restructuring expenses. The continued use of Wuhan as a delivery base preserves a local customer-support function after manufacturing ends there. The planned securities sales also show that Imasen is pursuing balance-sheet and portfolio measures alongside operational restructuring, while its unchanged earnings forecast provides the current financial outlook for the fiscal year ending March 2027.

Frequently Asked Questions

Why is Imasen consolidating its production operations in China?
Imasen is consolidating Chinese production to better align manufacturing capacity with automotive market demand, improve utilization at Guangzhou, and reduce fixed operating costs. The company plans to transfer all production from Wuhan Imasen to Guangzhou Imasen by the end of March 2027. Afterward, the Wuhan facility will remain as a delivery base serving customers in the Wuhan area. The restructuring is part of broader rationalization measures that include workforce adjustments and is intended to improve the profitability of Imasen's overall China business.

How much will Imasen's China restructuring cost?
Imasen expects to record an extraordinary loss of approximately JPY 1.2 billion for the fiscal year ending March 2027 as a result of the restructuring. The costs include the disposal of fixed assets that will no longer be needed after production is consolidated and employee compensation payments associated with the workforce adjustments. At the same time, Imasen expects approximately JPY 1.2 billion in extraordinary income from selling part of its holdings in two listed securities between October 2026 and March 2027. The company's consolidated earnings forecast remains unchanged.